United States · Series E startup
8 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$146Mraised across 8 rounds since 2007, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $14M sold, first sale Oct 2014
From a historical funding recordSEC filing: $14M sold, first sale Oct 2014
Reported by finsmes.comSEC filing: $7.5M sold, first sale Jun 2013
From a historical funding recordSEC filing: $20M sold, first sale Nov 2011
Reported by finsmes.comSEC filing: $12M sold, first sale Nov 2011
Reported by 3vbio.comSEC filing: $15M sold, first sale Jul 2009
No investor was named in the report.
From a historical funding record
From the SEC filings it signed: 2 on the team.
On the board, as filediBeth SeidenbergDavid MottGordon RingoldJames YoungJason FullerJinzi Jason WuMerdad ParseyRichard RodgersXufang Jason Duan
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise Associates
Kleiner Perkins Caufield & Byers
The Column Group
Rock Springs Capital
Ally Bridge Group
AscletisMissing a round, or an investor who was in one? Tell us.
3-V Biosciences's investors include New Enterprise Associates, Kleiner Perkins Caufield & Byers, The Column Group, Rock Springs Capital and Ally Bridge Group, and 1 more on record.
3-V Biosciences has raised $146M across 8 rounds since 2007.
3-V Biosciences's most recent round was a Series E of $18M in Feb 2019.
3-V Biosciences's largest round on record is $30M (Series B), in Jul 2009.
3-V Biosciences's first round on record, in Jul 2009, was backed by New Enterprise Associates, Kleiner Perkins Caufield & Byers and The Column Group.
3-V Biosciences's latest named round is a Series E, in Feb 2019.
3-V Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
